IntegraGen, Inc. Announces 45% Growth of Genomic Services in 2011  
3/6/2012 6:29:47 AM

EVRY, France--(BUSINESS WIRE)--IntegraGen, a biotechnology company dedicated to gene discovery and the development of molecular diagnostic products and services, announced today revenues for the year ending December 31, 2011. The company also announced the signing of two pharmacogenomic contracts and the launch of a new personalized sequencing service, the first offering of this type in France.